According to the report Asia Pacific Point-of-care Diagnostics Industry, published by Market Data Forecast, The Industry was worth $3.01 billion in 2016 and estimated to reach $4.92 billion by the end of 2021 with a CAGR of 10.28%.
Point-of-care diagnostics allow a speedy, convenient, and cost-efficient way to diagnose diseases at healthcare centers and hospitals. Point-of-care diagnostics is a term collectively used for diagnostic procedures and tests performed on-site. As compared to conventional in-laboratory tests, point-of-care diagnostics have the advantage of speed and convenience without compromising on consistency. Point-of-care diagnostics help cut down on the need for sophisticated diagnostic systems for regular tests like blood tests and urine tests.
Browse Industry data tables and in-depth TOC of the Asia Pacific Point-Of-Care Diagnostics Industry to 2021 @http://www.marketdataforecast.com/market-reports/asia-pacific-point-of-care-diagnostics-market-1562/
Many advanced point of care diagnostic products are on the verge of being used practically and widely. But, more than innovative and advanced point-of-care devices, there is an extensive need for inexpensive solutions that can be set up in regions where infectious diseases are highly prevalent. In developing regions, these tests are crucial in counterbalancing the lack of adequate laboratory capacity. This is one of the most promising opportunities that can be grabbed by Industry players.
In order to provide effective and fast diagnostic results, clinics and other healthcare establishments, are opting for point-of-care test, which are consequently influencing industrial growth. Advances in technology and introduction of cost effective and high quality medical solutions aimed at achieving miniaturization and lab automation are expected to serve the point-of-care diagnostics Industry as a vital driver. Additionally, healthcare practitioners have been observed to be increasingly more open and willing to adopt the use of point-of-care diagnostic consumables and medical devices thereby resulting in rapid demand and growth of this Industry. However, there are some certain Industry restraints that players need to overcome. The effort and co-ordination required among healthcare centers, researchers, practitioners and manufacturers is the greatest restraining factor for the growth of point-of-care diagnostics Industry. Also, reluctance from the industry towards changing the existing norms, frequent product recalls, stringent regulatory framework and unfavorable reimbursement scenario are some of the challenges faced by the point-of-care diagnostics Industry.
Free sample of the report is available @http://www.marketdataforecast.com/market-reports/asia-pacific-point-of-care-diagnostics-market-1562/request-sample
The Asia-Pacific point-of-care diagnostics Industry is segmented based on products, end-users and mode of delivery. Products have been segmented into Infectious Diseases, Cardiac Markers, Oncology Markers, OTC Diagnostic Tests, drugs of abuse, Blood Gas Testing, Fertility Testing, Urinalysis, Coagulation, Hematology, Glucose Monitoring, Ambulatory Chemistry, Decentralized Clinical Chemistry and others. By End-Users, the Industry has been further segmented as clinics, hospitals, home healthcare, ambulatory care settings, laboratories and others. Finally on the basis of delivery, the Industry has been segmented further into OTC and prescription modes of delivery.
Some of the major players in this Industry are Abbott Laboratories, Inc., Danaher Corporation, Roche Diagnostics Limited, BioMerieux, Siemens Healthcare, Beckman Coulter, Inc., Becton, Dickinson and Company, Johnson &Johnson ,Alere Inc., and PTS Diagnostics.
Key Points from Table of Contents
- Executive Summary
- Key Inferences
- New Developments
Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
Asia Pacific Point-Of-Care Diagnostics Industry: Segmentation
- Infectious Diseases
- Cardiac Markers
- Oncology Markers
- OTC Diagnostic Tests
- Drugs Of Abuse
- Blood Gas Testing
- Fertility Testing
- Glucose Monitoring
- Ambulatory Chemistry
- Decentralized Clinical Chemistry
- Home Healthcare
- Ambulatory Care Settings
- Mode of Delivery
- South Korea
- PESTLE analysis
- Porter’s Five analysis
Industry Leaders’ Analysis
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, we cater to the needs of both individual and corporate clients. Our analyst team comprises expert professionals in market research, who with their collective knowledge and skillset dedicatedly serve clients from various industries and regions.
Sales Manager (International Business Development)
Market Data Forecast
Direct Line: +1-888-702-9626
Mobile: +91 998 555 0206
Visit MarketDataForecast Blog @ http://www.marketdataforecast.com/blog/
View latest Press Releases of MDF @ http://www.marketdataforecast.com/press-releases